Evaluation of the efficacy of romosozumab for hemodialysis patients with hemodialysis
Not Applicable
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000039889
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are not receiving standard treatment for osteoporosis 2)Persons who are contraindicated in taking evenity or denosumab 3)Patients who have taken romosozumab or denosumab within 6 months 4)Hypocalcemia 5)Patients with severe liver dysfunction, heart dyfunction, malignant tumor 6)Patients who are judged by the investigator not to be eligible for drug administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method